[
    {
        "category": "company",
        "datetime": 1735656011,
        "headline": "Why Cencora (COR) is a Top Value Stock for the Long-Term",
        "id": 132221474,
        "image": "https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
        "url": "https://finnhub.io/api/news?id=0f9278b9dd8b0287424e9551ed6f00279e8983a7be2150c8aa38b9d3015ac05b"
    },
    {
        "category": "company",
        "datetime": 1735650660,
        "headline": "Is the Options Market Predicting a Spike in Cencora (COR) Stock?",
        "id": 132215210,
        "image": "https://media.zenfs.com/en/zacks.com/0f4791587a4b30058a8cb22f34ed0bc2",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Investors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately.",
        "url": "https://finnhub.io/api/news?id=1c6fe61dc65548244421199db3d7dc838a8193ccef10be99db725d1637408746"
    },
    {
        "category": "company",
        "datetime": 1735128019,
        "headline": "Is Cencora (NYSE:COR) Using Too Much Debt?",
        "id": 132143749,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
        "url": "https://finnhub.io/api/news?id=53bf429429caeb7a9eca236c9e697dcbcd03e5578c665f9fdfeceaf4d1cd0ccb"
    },
    {
        "category": "company",
        "datetime": 1735059360,
        "headline": "Cencora Inc. stock underperforms Tuesday when compared to competitors",
        "id": 132154058,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Tuesday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=5d0b9551126570a4c6df9c75a99969e89ad0094563587817874e068e8cc5d011"
    },
    {
        "category": "company",
        "datetime": 1734972960,
        "headline": "Cencora Inc. stock underperforms Monday when compared to competitors",
        "id": 132154059,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Monday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=bc3db7f6d4dbd6219ded877bd84e043dfd09d7e5db518d568c88bf4b8ac6a38d"
    },
    {
        "category": "company",
        "datetime": 1734713760,
        "headline": "Cencora Inc. stock rises Friday, still underperforms market",
        "id": 132154061,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock rises Friday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=305ee1178ba82ebb3e6755b7170bfd103c04a2cec8c566773e3c999aa652b49c"
    },
    {
        "category": "company",
        "datetime": 1734627300,
        "headline": "Cencora Inc. stock underperforms Thursday when compared to competitors",
        "id": 132154062,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Thursday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=a01f613b0f0a611f11cd16ed98bed5ca71e4d15d61064f8cb5c4262cb88e4926"
    },
    {
        "category": "company",
        "datetime": 1734540840,
        "headline": "Cencora Inc. stock outperforms competitors despite losses on the day",
        "id": 132154063,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock outperforms competitors despite losses on the day",
        "url": "https://finnhub.io/api/news?id=92455f1c4c44577306ac2bb48769d5cd1b28b8a98e7a5fbe3430dfd687d11c9f"
    },
    {
        "category": "company",
        "datetime": 1734519632,
        "headline": "Cencora's (NYSE:COR) earnings growth rate lags the 23% CAGR delivered to shareholders",
        "id": 132043791,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...",
        "url": "https://finnhub.io/api/news?id=ed5a5c385b2467d7b2846c8f94ceb3b7dc963b2fefb000badb8bb4d68e8624f1"
    },
    {
        "category": "company",
        "datetime": 1734369960,
        "headline": "Health Care Declines on Trump Administration Concerns -- Health Care Roundup",
        "id": 132151929,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Health Care Declines on Trump Administration Concerns -- Health Care Roundup",
        "url": "https://finnhub.io/api/news?id=9ece7b968046c7000f018ae8f12634b78fd052126caf8f97ab70f23ead2b7487"
    },
    {
        "category": "company",
        "datetime": 1734360313,
        "headline": "Why Cencora (COR) is a Top Growth Stock for the Long-Term",
        "id": 132012300,
        "image": "https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
        "url": "https://finnhub.io/api/news?id=3e9dda70c77b2b452f18fd924f83c3f396fbd2f5769df78f1d4597304f331acd"
    },
    {
        "category": "company",
        "datetime": 1734176126,
        "headline": "Cencora price target lowered to $237 from $249 at Wells Fargo",
        "id": 131984041,
        "image": "https://media.zenfs.com/en/tipranks_452/8948b64e92d23cb05c63afbc8ed98e4c",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Wells Fargo lowered the firm\u2019s price target on Cencora (COR) to $237 from $249 and keeps an Equal Weight rating on the shares. The firm updated estimates and price targets for the drug distribution group following the results and recent mergers. It is \u201cgenerally constructive\u201d on core distribution fundamentals into 2025, but says valuations and overhangs leave it neutral across the group. Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now",
        "url": "https://finnhub.io/api/news?id=6437326547445f5b8bd47fd3ce7ebe0bb41101c4f798641c469700001f5811f0"
    },
    {
        "category": "company",
        "datetime": 1733935980,
        "headline": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
        "id": 131943423,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=59482c426dca2cd8cba67f88323c354bf21417ae9b4c7518edc437148f15d060"
    },
    {
        "category": "company",
        "datetime": 1733848517,
        "headline": "CENCORA : CLOSES $1.8 BILLION SENIOR NOTES OFFERING Form 8 K",
        "id": 131908106,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "CENCORA CLOSES $1.8 BILLION SENIOR NOTES OFFERING CONSHOHOCKEN, PA, December 9, 2024 - Cencora, Inc. today announced the closing of its public offering of $500,000,000 aggregate...",
        "url": "https://finnhub.io/api/news?id=a4f5b3aa9eb3077e35248e4df002f988f2eef1c65c83a45de788ae21aaf7f271"
    },
    {
        "category": "company",
        "datetime": 1733778900,
        "headline": "Cencora Closes $1.8 Billion Senior Notes Offering",
        "id": 131897012,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., December 09, 2024--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500,000,000 aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the \"2027 Notes\"), $600,000,000 aggregate principal amount of its 4.850% Senior Notes due December 15, 2029 (the \"2029 Notes\") and $700,000,000 aggregate principal amount of its 5.150% Senior Notes due February 15, 2035 (the \"2035 Notes\" and, together with the 2027 Notes and the 2029 Notes,",
        "url": "https://finnhub.io/api/news?id=6ecff91595b3c6d58bb4bf4e0ad613683787dae08bf8881e36ec38ac931d6a68"
    },
    {
        "category": "company",
        "datetime": 1733511735,
        "headline": "We Think You Can Look Beyond Cencora's (NYSE:COR) Lackluster Earnings",
        "id": 131828594,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Soft earnings didn't appear to concern Cencora, Inc.'s ( NYSE:COR ) shareholders over the last week. We did some...",
        "url": "https://finnhub.io/api/news?id=787f3a80147d2f6779eff054bcdfd309da9fdf6e568a61c1d7b8229f7dd52733"
    },
    {
        "category": "company",
        "datetime": 1733504040,
        "headline": "Cencora Inc. stock underperforms Friday when compared to competitors",
        "id": 131883475,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Friday when compared to competitors",
        "url": "https://finnhub.io/api/news?id=6dd7e3bb12dc4a7215fb2e2208d8fd0c279b6ec975ed9731eb22079bb8f191c5"
    },
    {
        "category": "company",
        "datetime": 1733394413,
        "headline": "Cencora: Competitive Advantages Defined",
        "id": 131792710,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1220627489/image_1220627489.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Cencora\u00e2\u0080\u0099s low-cost model and negative net working capital ensure resilience. Find out why COR stock\u00e2\u0080\u0099s competitive advantages lead to consistent cash flow.",
        "url": "https://finnhub.io/api/news?id=db6121cbbb0a1ed6a46bbadaf12ad8160b24b3db77b4b55e759001eafbf68447"
    },
    {
        "category": "company",
        "datetime": 1733310019,
        "headline": "Possible Bearish Signals With Cencora Insiders Disposing Stock",
        "id": 131796948,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have...",
        "url": "https://finnhub.io/api/news?id=016a3ed2aa459c586deb7533aa218e668fcfc69a2b9d8ca63f3cea469d4a6a47"
    },
    {
        "category": "company",
        "datetime": 1733244780,
        "headline": "Cencora Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
        "id": 131783999,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
        "url": "https://finnhub.io/api/news?id=b3f871c8a84e7fb8f4a059e2840983310e78a7142df85c7d4332f95b77e97238"
    },
    {
        "category": "company",
        "datetime": 1733197740,
        "headline": "Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035",
        "id": 131747186,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., December 03, 2024--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the \"2027 Notes\"), $600 million aggregate principal amount of its 4.850% Senior Notes due December 15, 2029 (the \"2029 Notes\") and $700 million aggregate principal amount of its 5.150% Senior Notes due February 15, 2035 (the \"2035 Notes\" and, together with the 2027 Notes and the 2029 Notes, the \"Notes\"), in an und",
        "url": "https://finnhub.io/api/news?id=b59e1a1d752a4f002a74bd36fb1a0c6b8cca219b07364b62f18f8b6caa87c319"
    },
    {
        "category": "company",
        "datetime": 1733167329,
        "headline": "Here's Why Cencora (COR) is a Strong Momentum Stock",
        "id": 131747187,
        "image": "https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "url": "https://finnhub.io/api/news?id=f102091238c13e2289b1421c084ef2453a4fdeec77d31603cc355c60538918fe"
    },
    {
        "category": "company",
        "datetime": 1732940400,
        "headline": "TimesSquare U.S. Mid Cap Growth Q3 2024 Commentary",
        "id": 131720280,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2060695704/image_2060695704.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Amidst this environment, the portfolio underperformed the Russell Midcap Growth Index in the third quarter.",
        "url": "https://finnhub.io/api/news?id=faa744cd608834b5b36f55dd447843ff401e6d36384b43494884b22a2e7334cb"
    },
    {
        "category": "company",
        "datetime": 1732899180,
        "headline": "Cencora Inc. stock underperforms Friday when compared to competitors despite daily gains",
        "id": 131784003,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Friday when compared to competitors despite daily gains",
        "url": "https://finnhub.io/api/news?id=a2d484a366a6f649b1d71bbc2ef80582a21f8f802fb9ab64650b9003d5a11578"
    },
    {
        "category": "company",
        "datetime": 1732322964,
        "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of November 24",
        "id": 131580991,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Stay informed on dividend activity with a weekly summary for Dividend Champions, Contenders, and Challengers, including changes and upcoming dates.",
        "url": "https://finnhub.io/api/news?id=46b10c8d9bc9861490c2c84151efd9f63a786791d479fa6bd02cf1d03ac61604"
    },
    {
        "category": "company",
        "datetime": 1732207980,
        "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
        "id": 131607326,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
        "url": "https://finnhub.io/api/news?id=569d61928ffd8a6034dc7434194164a081f15e24900b7516ca718719400ba3f0"
    },
    {
        "category": "company",
        "datetime": 1732007700,
        "headline": "IXJ: Healthcare Sector\u00a0Dashboard For November",
        "id": 131471159,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688000635/image_688000635.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.",
        "url": "https://finnhub.io/api/news?id=17b2ae374f72b898be1e13a220d648b578b5b9ae1db05e9f4365ec93e3d05504"
    },
    {
        "category": "company",
        "datetime": 1731915120,
        "headline": "Walgreens: 11.9% Dividend Yield Still On Unsteady Legs",
        "id": 131440349,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1203973115/image_1203973115.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Walgreens Boots Alliance's 11.9% dividend yield is not covered by free cash flow. Read what makes WBA stock a risky investment.",
        "url": "https://finnhub.io/api/news?id=489466e87902f93baa4b642dd7db4a67433b761cd6eda78240ac5a69cf8e27fd"
    },
    {
        "category": "company",
        "datetime": 1731896594,
        "headline": "Merck Among 10 Companies To Announce Annual Dividend Increases In Second Half Of November",
        "id": 131437317,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210931291/image_1210931291.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "I expect 10 companies to announce their annual increases in the second half of November. Click here for a detailed analysis.",
        "url": "https://finnhub.io/api/news?id=a17e850a03d211ec74e1268d17f8ffbea7a0baa516edc4f0309e99b7308b1f0a"
    },
    {
        "category": "company",
        "datetime": 1731540420,
        "headline": "McKesson Stock Gets A RS Rating Lift To 75",
        "id": 131338756,
        "image": "https://media.zenfs.com/en/ibd.com/62147566276b3a75eab1ea938001a116",
        "related": "COR",
        "source": "Yahoo",
        "summary": "A Relative Strength Rating upgrade for McKesson shows improving technical performance. Will it continue?",
        "url": "https://finnhub.io/api/news?id=62ba3747cc7c01c190f5b89f0527337ed7d76050bced475ddae2d3f98d005dee"
    },
    {
        "category": "company",
        "datetime": 1731516780,
        "headline": "Cencora Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
        "id": 131423176,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
        "url": "https://finnhub.io/api/news?id=4cec32fec3197e8cfeae8ca1b6d55467e992c2592435b02a93219a5f54b8ee31"
    },
    {
        "category": "company",
        "datetime": 1731509111,
        "headline": "Here's Why Cencora (COR) is a Strong Growth Stock",
        "id": 131341700,
        "image": "https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
        "url": "https://finnhub.io/api/news?id=a42682eaa3d5473b32ca94746ae791335a4e5992c80ddfdbc8d2d94b1ec29394"
    },
    {
        "category": "company",
        "datetime": 1731499069,
        "headline": "Baltimore wins $266 million in opioid case against distributors",
        "id": 131327497,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an epidemic of opioid addiction in the U.S., and is expected to seek billions more...",
        "url": "https://finnhub.io/api/news?id=5fa842025449ae006c230e3e811bc2393019814dbacb3a3baccf9451e81d7b08"
    },
    {
        "category": "company",
        "datetime": 1731348786,
        "headline": "Cencora Full Year 2024 Earnings: EPS Misses Expectations",
        "id": 131289630,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora ( NYSE:COR ) Full Year 2024 Results Key Financial Results Revenue: US$294.0b (up 12% from FY 2023). Net income...",
        "url": "https://finnhub.io/api/news?id=5c7563d0890cdd9ba23644e3b3983201a880988e972a1724581e7d3a052fe179"
    },
    {
        "category": "company",
        "datetime": 1731336612,
        "headline": "Why Cencora (COR) is a Top Momentum Stock for the Long-Term",
        "id": 131289631,
        "image": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "url": "https://finnhub.io/api/news?id=88470ed7cf36855a3ed9a87d14d8800c94c3f219cdae8a4c9972f0ae11d4a5d4"
    },
    {
        "category": "company",
        "datetime": 1731153765,
        "headline": "Cencora's (NYSE:COR) Dividend Will Be Increased To $0.55",
        "id": 131254248,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora, Inc.'s ( NYSE:COR ) dividend will be increasing from last year's payment of the same period to $0.55 on 29th...",
        "url": "https://finnhub.io/api/news?id=5f76d6049a0e6c260fe0f640aaad23726a389c5002b4f4e011f077360e78cd01"
    },
    {
        "category": "company",
        "datetime": 1731113829,
        "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of November 10",
        "id": 131241650,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Stay up to date on dividend activity with our weekly summary for Dividend Champions, Contenders, and Challengers, including ex-dividend and pay dates.",
        "url": "https://finnhub.io/api/news?id=7bb046f52c6ac7dc03f4cbcf804093f36b553e4b1ff2f7cc14d8de36e3acdab9"
    },
    {
        "category": "company",
        "datetime": 1731098220,
        "headline": "Cardinal Health Stock Sees IBD RS Rating Improve To 71",
        "id": 131229659,
        "image": "",
        "related": "COR",
        "source": "Yahoo",
        "summary": "A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?",
        "url": "https://finnhub.io/api/news?id=fa862458814682fd0840a1710002e61b853c98c5466dd48e8af9e444b3ed1022"
    },
    {
        "category": "company",
        "datetime": 1731049774,
        "headline": "Cencora : Advances Specialty Leadership Through Acquisition of Retina Consultants of America Form 8 K",
        "id": 131212920,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America CONSHOHOCKEN, PA, November 6, 2024 - Cencora, Inc. today announced that it has entered into...",
        "url": "https://finnhub.io/api/news?id=532229a1b7f7831d22a1a5c83e9d5ee017dae601ed205c44f6a2462cf5438dd7"
    },
    {
        "category": "company",
        "datetime": 1730998380,
        "headline": "Cencora Inc. stock underperforms Thursday when compared to competitors despite daily gains",
        "id": 131202094,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock underperforms Thursday when compared to competitors despite daily gains",
        "url": "https://finnhub.io/api/news?id=4582e83e6b03f0303401ee0b1b39a6157b08ebe236ef076ec195e889a62d16f4"
    },
    {
        "category": "company",
        "datetime": 1730980903,
        "headline": "Cencora Reports Strong Revenue and EPS Growth in 2024",
        "id": 131174469,
        "image": "https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora ( (COR) ) just unveiled an update. Cencora, Inc. reported significant growth in its fiscal 2024 results, boasting a 14.7% increase in fourth-quarter revenue to $79.1 billion and a 12.1% rise for the year to $294.0 billion. Despite a drop in GAAP diluted EPS to $0.02 in the fourth quarter, adjusted EPS saw a robust 16.8% rise to $3.34. The company enhanced its strategic pharmaceutical distribution capabilities and expanded its specialty services with the acquisition of Retina Consultants",
        "url": "https://finnhub.io/api/news?id=5f8e24fd532bf7a888f84c355f00b3f9ddcf705987d5385718d3fba453b59e53"
    },
    {
        "category": "company",
        "datetime": 1730979360,
        "headline": "Cencora to acquire Retina Consultants of America for $4.6B in cash",
        "id": 131174471,
        "image": "https://media.zenfs.com/en/tipranks_452/373719bd4f9106065622fdb013c92607",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora (COR) announced that it has entered into a definitive agreement to acquire Retina Consultants of America, a management services organization of retina specialists, from Webster Equity Partners. Cencora will acquire RCA for approximately $4.6B in cash, subject to a customary working capital and net-debt adjustment. RCA\u2019s affiliated practices, physicians and management will retain a minority interest in RCA, with Cencora holding approximately 85% ownership in RCA upon closing. Additionally",
        "url": "https://finnhub.io/api/news?id=8db7aab7c8d34dfd71ad13a7aee1a14125ae55a2d3c078b9fcfcb082534f34eb"
    },
    {
        "category": "company",
        "datetime": 1730904013,
        "headline": "Here's Why Cencora (COR) is a Strong Value Stock",
        "id": 131150673,
        "image": "https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "url": "https://finnhub.io/api/news?id=629600c73ca10a44eabbabcfdda5564c2a0c2aad3f67c070fc39a85ed6b59262"
    },
    {
        "category": "company",
        "datetime": 1730892900,
        "headline": "Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results",
        "id": 131105384,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., November 06, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 billion. Revenue increased 12.1 percent to $294.0 billion for the fiscal year. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $0.02 for the September quarter of fiscal 2024, compared to $1.72 in the prior year quarter. Adjusted diluted EPS, which is a",
        "url": "https://finnhub.io/api/news?id=a348695c82334a2bc4b8aa7230faac2424eb21a6ec85ccba48b85a03c82e8e9f"
    },
    {
        "category": "company",
        "datetime": 1730892600,
        "headline": "Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America",
        "id": 131105387,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., November 06, 2024--Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (\"RCA\"), a leading management services organization (MSO) of retina specialists, from Webster Equity Partners.",
        "url": "https://finnhub.io/api/news?id=d37f3f46b8a85185aa9748238de83475d21fe861a5d9911319cf3e370c9827a5"
    },
    {
        "category": "company",
        "datetime": 1730890588,
        "headline": "Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript",
        "id": 131108287,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Cencora, Inc. (NYSE:COR) Q4 2024 Earnings Call Transcript November 6, 2024 8:30 AM ETCompany ParticipantsBennett Murphy - SVP, Head of IRBob Mauch -...",
        "url": "https://finnhub.io/api/news?id=3359b2ab312d8c40dff30378d865559241f113143deb45182bda409896a84219"
    },
    {
        "category": "company",
        "datetime": 1730882668,
        "headline": "Cencora, Inc. 2024 Q4 - Results - Earnings Call Presentation",
        "id": 131106704,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "The following slide deck was published by Cencora, Inc.",
        "url": "https://finnhub.io/api/news?id=a93ed67c4c9688fbfc097d60fa571e124899d300e9bf2e3326c85cc5ee9a1e3b"
    },
    {
        "category": "company",
        "datetime": 1730875446,
        "headline": "CENCORA : REPORTS FISCAL 2024 FOURTH QUARTER AND YEAR END RESULTS Form 8 K",
        "id": 131104933,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "CENCORA REPORTS FISCAL 2024 FOURTH QUARTER AND YEAR END RESULTS Revenue of $79.1 Billion for the Fourth Quarter, a 14.7 Percent Year-Over-Year Increase Fourth Quarter...",
        "url": "https://finnhub.io/api/news?id=43c064ab7d1134d9f053e6e2caf7a0330b8e017340eaccd3274a748f13d93991"
    },
    {
        "category": "company",
        "datetime": 1730875445,
        "headline": "Cencora : Fourth Quarter 2024 Presentation",
        "id": 131104935,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "Cencora, Inc. Fourth Quarter Fiscal 2024 Earnings Call November 6, 2024 Cautionary Note...",
        "url": "https://finnhub.io/api/news?id=ecf106d1555fadb048a0a2b75426a9687a782e609d0fbcb312e6abb2a2596292"
    },
    {
        "category": "company",
        "datetime": 1730875145,
        "headline": "Cencora : Fourth Quarter 2024 News Release",
        "id": 131104868,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "Cencora, Inc. today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 billion. Revenue increas...",
        "url": "https://finnhub.io/api/news?id=1c03b7d60ff52d37aa9c3aabadaadac37c7153f6e8f945556ed2942751cb9ede"
    },
    {
        "category": "company",
        "datetime": 1730834520,
        "headline": "Cencora 4Q Sales Climb While Profit Falls on Higher Costs",
        "id": 131113872,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora 4Q Sales Climb While Profit Falls on Higher Costs",
        "url": "https://finnhub.io/api/news?id=503462b2a89e35144bc07f776410ae30ec358081051ef12f206c990504c55f9a"
    },
    {
        "category": "company",
        "datetime": 1730832720,
        "headline": "Cencora to Acquire Retina Consultants of America for $4.6B",
        "id": 131113873,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora to Acquire Retina Consultants of America for $4.6B",
        "url": "https://finnhub.io/api/news?id=72c2e6c163524995f5b0fb31be1d46d976c628af0ec7c9af3706c5cc939f570e"
    },
    {
        "category": "company",
        "datetime": 1730782440,
        "headline": "Cencora Inc. stock rises Tuesday, still underperforms market",
        "id": 131113874,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Inc. stock rises Tuesday, still underperforms market",
        "url": "https://finnhub.io/api/news?id=9a196e92b8251d44f82b35f2b8abc249e93be9f80dfa8fe7304a3681ec311f50"
    },
    {
        "category": "company",
        "datetime": 1730727000,
        "headline": "Cencora Expands Enterprise Leadership Team with Two Senior Appointments",
        "id": 131053945,
        "image": "https://media.zenfs.com/en/business-wire.com/10b0dc233a3b26d678e3df0a1143695e",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., November 04, 2024--Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President, Strategy and M&A, and Pawan Verma as Executive Vice President, Chief Data and Information Officer. Both leaders will join Cencora\u2019s enterprise leadership team, bringing their extensive experience and expertise to help advance the company\u2019s pharmaceutical-centric strategy and drive growth for Cencora and its customers.",
        "url": "https://finnhub.io/api/news?id=56a7e88f072fe6f45a05555148c39d0c4f8f6a85eea476ede60c172b389efd18"
    },
    {
        "category": "company",
        "datetime": 1730674283,
        "headline": "Becton, Dickinson And HP Among 13 Companies To Announce Annual Dividend Increases In First Half Of November",
        "id": 131034503,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/863884318/image_863884318.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "I expect 13 companies to announce their annual increases in the first half of November. Click here for a detailed analysis.",
        "url": "https://finnhub.io/api/news?id=d27a1d89b6d3daea5892871547368821a65737f2f76b91cc6277b365daeba05b"
    },
    {
        "category": "company",
        "datetime": 1730479328,
        "headline": "Dividend Aristocrats Of The Future - Part 3",
        "id": 130971760,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1454448091/image_1454448091.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Discover the final group of 10 companies on track to become dividend aristocrats in the next 5 years, with high-growth rates and special dividends.",
        "url": "https://finnhub.io/api/news?id=be0e3744f5a218aeb26c513b8619c261e7bc603ea6a55cb1d864b1e78550ae8f"
    },
    {
        "category": "company",
        "datetime": 1730459100,
        "headline": "Cencora Inc (COR) Trading 3.22% Higher on Nov 1",
        "id": 130960026,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fb7a8be70f84c7f3a9732f2e9bd436efba28d3c6c0b1819ae776dc34c8330430"
    },
    {
        "category": "company",
        "datetime": 1730169120,
        "headline": "McKesson, Cardinal Health draw ire of Sen. Warren over cancer deals",
        "id": 130820842,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=228d44656bb8129332e42c297ee68ea6bc2615421147d04698f8ace22ec7f4b8"
    },
    {
        "category": "company",
        "datetime": 1730121443,
        "headline": "Cencora : Participation in the White House Cancer Moonshot\u2019s New Pilot to Mitigate Pediatric Cancer Drug Shortages",
        "id": 130780441,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate...",
        "url": "https://finnhub.io/api/news?id=69dda619da7f1a61c2f04c5d3b71d00c052db833dbfadb59c43865a162ac39a6"
    },
    {
        "category": "company",
        "datetime": 1730094180,
        "headline": "Camino Minerals Reports Progress on Peruvian Project",
        "id": 130780333,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=397b64737864bb2ee82d89b84c73f3a314ce4dd814db281e98273e0dc56d3cfe"
    },
    {
        "category": "company",
        "datetime": 1730092740,
        "headline": "Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru",
        "id": 130780334,
        "image": "",
        "related": "COR",
        "source": "Accesswire",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=74361e6147c9eab4d349d403248378f4666da73288bbbd0fcd9f5017b277d4dd"
    },
    {
        "category": "company",
        "datetime": 1729944024,
        "headline": "We Think Cencora (NYSE:COR) Can Stay On Top Of Its Debt",
        "id": 130756800,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...",
        "url": "https://finnhub.io/api/news?id=c6854d9e16a8061fd4fe7957bd00eb87b0dc8be74122d35dd41e2839ea023a95"
    },
    {
        "category": "company",
        "datetime": 1729744260,
        "headline": "If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today",
        "id": 130741583,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=4f84f92609b85b7bfa36615edb916fa5bd2dc6a40b3d31b9b6a1dde51dda758d"
    },
    {
        "category": "company",
        "datetime": 1729659660,
        "headline": "Executive Chairman Steven Collis Sells 21,509 Shares of Cencora Inc (COR)",
        "id": 130687363,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=a0d75bc1bd65cc2aa9bf15a3efab27907b2bbda433748d7cdd4fe732ea874c21"
    },
    {
        "category": "company",
        "datetime": 1729575600,
        "headline": "Camino Minerals Unveils New Copper Zones in Peru",
        "id": 130658753,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=cbaaf2484c11692537bf6c3bd26aae3de85e4908fb24b062d2e59e665b34b028"
    },
    {
        "category": "company",
        "datetime": 1729573200,
        "headline": "Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru",
        "id": 130658754,
        "image": "",
        "related": "COR",
        "source": "Accesswire",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=2d8c3956a47a53d2e6783d8b2df1f6364832433cf079deddab6b4cc1f1abf65d"
    },
    {
        "category": "company",
        "datetime": 1729255980,
        "headline": "Cencora secures $2B modification contract for U.S. defense logistics",
        "id": 130561274,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=67b7b10390f1e4a18130dcad316110e06954ec09f3b7a70d1a98233637f0878d"
    },
    {
        "category": "company",
        "datetime": 1729214280,
        "headline": "CVS could face long arduous turnaround like Walgreens",
        "id": 130575901,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=e21a0439f1f6910f82b51f6bf316715d454737fc2ec3231376487e8987d8285a"
    },
    {
        "category": "company",
        "datetime": 1729008617,
        "headline": "Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?",
        "id": 130486630,
        "image": "https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
        "url": "https://finnhub.io/api/news?id=98f12e10420bf997d4e3e10af5108c5d0d1ba6f3425616b89a1dfa176f7a8d15"
    },
    {
        "category": "company",
        "datetime": 1728990300,
        "headline": "Cencora Inc (COR) Stock Price Up 3.74% on Oct 15",
        "id": 130469628,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=5de7bf3cbf6c5da6273053ac77d87f8235d71bd80077f8668593afa5e6bbf45c"
    },
    {
        "category": "company",
        "datetime": 1728986940,
        "headline": "COR Makes Bullish Cross Above Critical Moving Average",
        "id": 130469630,
        "image": "",
        "related": "COR",
        "source": "Dividend Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=d3074afe9ca219111fd5ccb8cf25cafb47c483f1765e45cf9e9ff8cf6146dafb"
    },
    {
        "category": "company",
        "datetime": 1728975720,
        "headline": "Cencora, Inc. (COR) Announces Amendments to Credit and Securitization Facilities",
        "id": 130501532,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=c700f308dfb2e92c88a0791b13f2809f9ee351b5bba49173bc14e3d540f09ecb"
    },
    {
        "category": "company",
        "datetime": 1728916079,
        "headline": "IYH: Healthcare Dashboard For October",
        "id": 130446932,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/875483832/image_875483832.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "iShares U.S. Healthcare report reveals the sector is overvalued by 20% compared to 11-year averages. Learn more about IYH ETF and its diverse holdings!",
        "url": "https://finnhub.io/api/news?id=8f53ccfc3a48c118769067f3221cb11a45cc8c74475130aaf543d8ff76e4887a"
    },
    {
        "category": "company",
        "datetime": 1728892620,
        "headline": "Morgan Stanley Keeps Their Hold Rating on Cencora (COR)",
        "id": 130445277,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=6f2fe0f7ef95bd8551fcff431d0391cf17ceeac755b6e8f5a410ca30250740e6"
    },
    {
        "category": "company",
        "datetime": 1728565220,
        "headline": "If EPS Growth Is Important To You, Cencora (NYSE:COR) Presents An Opportunity",
        "id": 130376898,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...",
        "url": "https://finnhub.io/api/news?id=67c6cb40ff8fac6153cd45ffb9b241dbbca02780420761a9cfb11672c9408cd2"
    },
    {
        "category": "company",
        "datetime": 1728555900,
        "headline": "TimesSquare U.S. Mid Cap Growth Strategy Q3 2024 Commentary",
        "id": 130349462,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1407499490/image_1407499490.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "TimesSquare U.S. Mid Cap Growth Strategy\u00c2\u00a0underperformed the Russell Midcap\u00c2\u00ae Growth Index in the third quarter of 2024. Click here to read the full commentary.",
        "url": "https://finnhub.io/api/news?id=fa5f018b8f5fe7e9de728350572a7d365bf9e2aee18a4f889f417e1109fc882d"
    },
    {
        "category": "company",
        "datetime": 1728500455,
        "headline": "McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff",
        "id": 130327021,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1961399015/image_1961399015.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "McKesson Corporation was the highest-scoring large cap on the most recent Magic Formula screen for Oct. 2024. Click here to read an analysis of MCK stock now.",
        "url": "https://finnhub.io/api/news?id=e3982031998234f11639feb16fbb78562b6a3756810c39101bc3ad7d9dcd77f3"
    },
    {
        "category": "company",
        "datetime": 1728475560,
        "headline": "$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today",
        "id": 130319857,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=4c753186735aaa9c23f2073f3495769e2762f6d0c7dd67fd28d41d624d7319c8"
    },
    {
        "category": "company",
        "datetime": 1728379412,
        "headline": "My Top 3 Large Cap Magic Formula Stocks For October 2024",
        "id": 130276599,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1661674291/image_1661674291.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Discover the top decile of the Magic Formula 30 large cap screen for consistent outperformance in stock selection based on earnings yield and ROIC.",
        "url": "https://finnhub.io/api/news?id=3768a17fe6e2001b94cfa709c0ab4d9717baae6b4f8d23febb4ba53444accb47"
    },
    {
        "category": "company",
        "datetime": 1728371940,
        "headline": "Cencora price target lowered by $20 at Evercore ISI, here's why",
        "id": 130292350,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=2116577891ff75dbb6c181df7cc8ff7f2ca00fe03529a832e1d7689cd674a965"
    },
    {
        "category": "company",
        "datetime": 1728292200,
        "headline": "Camino Minerals Expands Copper Holdings in Chile",
        "id": 130257705,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=bae8a838d1b3529fcfa3f68d18791c80b7e44534944562c612addf93b846c24e"
    },
    {
        "category": "company",
        "datetime": 1728291840,
        "headline": "Analyst Scoreboard: 6 Ratings For Cencora",
        "id": 130257706,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=edf1657e7f903401075e114d216a672af01f4530ff7c40316d0c206ec47442b3"
    },
    {
        "category": "company",
        "datetime": 1728289920,
        "headline": "Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile",
        "id": 130257708,
        "image": "",
        "related": "COR",
        "source": "Accesswire",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fb8c56a992bebae563da0595db1588b1c8402c023c8515b49b3e7eeecd8aa8a0"
    },
    {
        "category": "company",
        "datetime": 1728116760,
        "headline": "If I Had To Invest $150,000 Right Now, Here's What I Would Buy",
        "id": 130231536,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1462296278/image_1462296278.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Discover 15 top stock and ETF picks for a $150,000 lump sum investment, aimed at long-term growth and minimal monitoring, with dividends as a bonus.",
        "url": "https://finnhub.io/api/news?id=29096fcb008528d00ab51dbc565d6a2269b62e0789a055e54ae81ad104c62509"
    },
    {
        "category": "company",
        "datetime": 1728046827,
        "headline": "Those who invested in Cencora (NYSE:COR) five years ago are up 193%",
        "id": 130278683,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...",
        "url": "https://finnhub.io/api/news?id=b645c5afbbb7a2ad6d6fae44b9836d446bf1cf0d4e5083655757f3d7eee9a8e8"
    },
    {
        "category": "company",
        "datetime": 1728038640,
        "headline": "Cencora Becomes Oversold",
        "id": 130227869,
        "image": "",
        "related": "COR",
        "source": "Dividend Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=76261b581e5f2862cf189d46ddcf97ee12e51f80ce704e22a97a70600c6f0578"
    },
    {
        "category": "company",
        "datetime": 1728006000,
        "headline": "Cencora: A Strong Buy on Consistent Financial Excellence and Strategic Partnerships",
        "id": 130227635,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=ed457e1ef9133390fd2278d3adfddb6109f32808e40c9c00db94b2388858fa6c"
    },
    {
        "category": "company",
        "datetime": 1727782200,
        "headline": "Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release",
        "id": 130169627,
        "image": "",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., October 01, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2024 on Wednesday, November 6, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 6, 2024.",
        "url": "https://finnhub.io/api/news?id=0ad73f95e653acfa3d82647a9c0d2778c23ed173dd08f7e3be3840fc8e9b586d"
    },
    {
        "category": "company",
        "datetime": 1727434800,
        "headline": "Why Drug Distributors Are Buying Cancer Specialists",
        "id": 130104500,
        "image": "https://s.yimg.com/ny/api/res/1.2/LYfK0Mn9mYkNRxGs3YaQeA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/6e1e7c7938b7af9d106120fa20df6423",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Most Americans pick up their prescription drugs at the local pharmacy, but many pricey medications are bought directly by medical providers.  Think, for example, of a chemotherapy infusion delivered at a doctor\u2019s office.  Now, the big three U.S. drug wholesalers\u2014  McKesson Cencora  and  Cardinal Health  \u2014are taking control of the doctors, too, to lock them in as customers.",
        "url": "https://finnhub.io/api/news?id=98f879bf1c0f8da75c66b7504afc2ecf710919692ebee40420abce722ad1fbec"
    },
    {
        "category": "company",
        "datetime": 1727087940,
        "headline": "Goldman rebalances low labor cost basket amid cooling labor market",
        "id": 130023366,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fe5d693eae0194a31edcb89fd8102b143b338298bddcb62c57aa6b0e7e64a0f1"
    },
    {
        "category": "company",
        "datetime": 1726830030,
        "headline": "These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well",
        "id": 129982923,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...",
        "url": "https://finnhub.io/api/news?id=03b129f52cfb712002f0d7f67a88603b0efdc5c1e5a08f6fa5ccc2827f96fc77"
    },
    {
        "category": "company",
        "datetime": 1726744560,
        "headline": "May 2025 Options Now Available For Cencora (COR)",
        "id": 129969306,
        "image": "",
        "related": "COR",
        "source": "Stock Options Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=cac83ca28be3ef32311191b3836bb678b850cc39d9fed931437010cc5f6bacb1"
    },
    {
        "category": "company",
        "datetime": 1726684404,
        "headline": "B of A Securities Downgrades Cencora (COR)",
        "id": 129946625,
        "image": "",
        "related": "COR",
        "source": "Fintel",
        "summary": "",
        "url": "https://finnhub.io/api/news?id=36a447ad9d20007c724be18123f3e686fc5e95f06d34d80af16d963e2ff16c8a"
    },
    {
        "category": "company",
        "datetime": 1726655940,
        "headline": "Cencora cut to Neutral at BofA; risks to Walgreens, Cigna contracts cited",
        "id": 129945919,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=46e3ffdc0561418e116d2c13e61810b1c2d5f9a6be18b506620da79fab7d033c"
    },
    {
        "category": "company",
        "datetime": 1726653600,
        "headline": "COR Crosses Below Key Moving Average Level",
        "id": 129954561,
        "image": "",
        "related": "COR",
        "source": "Dividend Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=39aa6bbdf3af72d82eadb3d43b9b3ccc060623d86a8ae4d32d4f82681b1ec994"
    },
    {
        "category": "company",
        "datetime": 1726648800,
        "headline": "Nvidia, ARM initiated: Wall Street's top analyst calls",
        "id": 129945511,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=1ee38746e11c67018f52c344a5310edfb15ebee8bae87a9b78dcdbc5fbeea909"
    },
    {
        "category": "company",
        "datetime": 1726636500,
        "headline": "Cencora just downgraded at BofA, here's why",
        "id": 129954564,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=f9c097d83ba3ef4ef0db4ce475c67aec1b24bf23bdcc65bdd414ee279a2f76b8"
    },
    {
        "category": "company",
        "datetime": 1726635720,
        "headline": "Insider Sale: Cencora Inc (COR) CEO Steven Collis Sells 21,509 Shares",
        "id": 129954565,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=324e840046781d185fad9f87910068ec0f4c33ae0b4959e8dc8a7bb1781074bf"
    },
    {
        "category": "company",
        "datetime": 1726630989,
        "headline": "Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating",
        "id": 129938592,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/520290362/image_520290362.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "I recommend a Hold rating for Cencora stock despite strong growth, citing specific concerns that suggest waiting to reassess in 6-12 months. Read more here.",
        "url": "https://finnhub.io/api/news?id=d219146822cdf23becd1764f5eaaea85d9219e8bd0f3f8a132a6d19402d4bd3c"
    },
    {
        "category": "company",
        "datetime": 1726621500,
        "headline": "These are the mid-caps that could perform best during \u2018downturn\u2019 regimes \u2013 BofA",
        "id": 129947171,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=f4dadc0cb74205d460561c51f9d41693c415fe995ba744a3bfda7303137d1119"
    },
    {
        "category": "company",
        "datetime": 1726537320,
        "headline": "Tuesday Sector Laggards: Healthcare, Utilities",
        "id": 129934153,
        "image": "",
        "related": "COR",
        "source": "Market News Video",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fa3fe51b2677e3ba589fe57c7754e999bd784871b22d5e051ef037883cef1f3a"
    },
    {
        "category": "company",
        "datetime": 1726509025,
        "headline": "IHF: Healthcare Dashboard For September",
        "id": 129909507,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1555515663/image_1555515663.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "iShares\u00c2\u00a0U.S. Healthcare Providers ETF holds a portfolio of 66 stocks and is very concentrated. Learn more on IHF here.",
        "url": "https://finnhub.io/api/news?id=641978f08c77abe585a0ef542ed1c487fc75c588de15a15eca092cfa4c452c4c"
    },
    {
        "category": "company",
        "datetime": 1726318819,
        "headline": "Cencora Insiders Sell US$13m Of Stock, Possibly Signalling Caution",
        "id": 129883068,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The fact that multiple Cencora, Inc. ( NYSE:COR ) insiders offloaded a considerable amount of shares over the past year...",
        "url": "https://finnhub.io/api/news?id=c45682af3c09863d0b2c2333fad14b2cceecffe85dac0181f4089ba0bd088f27"
    },
    {
        "category": "company",
        "datetime": 1726316280,
        "headline": "Walgreens Boots Alliance, Inc. Reduces Stake in BrightSpring Health Services Inc.",
        "id": 129882588,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=b7362b4f467101c5a5c95e7cfde247fcdbf18c338a284f873407dd348fbf6e43"
    },
    {
        "category": "company",
        "datetime": 1725966066,
        "headline": "Here's Why We Think Cencora (NYSE:COR) Might Deserve Your Attention Today",
        "id": 129801417,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
        "url": "https://finnhub.io/api/news?id=0d5998c72e072e4d0657b0f5476a2dd5907aace4400837a1553af600d4d9ce89"
    },
    {
        "category": "company",
        "datetime": 1725955200,
        "headline": "Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team",
        "id": 129814401,
        "image": "",
        "related": "COR",
        "source": "Business Wire",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=870479657095f6261f6c680bd1b903b7869ab979c3ebfd43a37b60bd7cd231f4"
    },
    {
        "category": "company",
        "datetime": 1725615120,
        "headline": "Interesting COR Put And Call Options For September 2025",
        "id": 129746342,
        "image": "",
        "related": "COR",
        "source": "Stock Options Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=48d5e0bea6f34e9a5373b75fc146775a750ac67f5a7491a6f04bae2681bc114c"
    },
    {
        "category": "company",
        "datetime": 1725610200,
        "headline": "Cencora price target lowered by $4 at Baird, here's why",
        "id": 129770946,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=e8749589a189d5c1254eb698a3f4d92a9a2e5c9255a70df14e289296896c3455"
    },
    {
        "category": "company",
        "datetime": 1725610200,
        "headline": "Election 2024: Where To Put Your Money Ahead of the Vote",
        "id": 129764987,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=89dc06d7b645c79b3bd1a812e192b2a5a30040e8f85c11b41b03863725b669de"
    },
    {
        "category": "company",
        "datetime": 1725528600,
        "headline": "Cencora lifts 2024 guidance; future growth at bottom end of targets",
        "id": 129729971,
        "image": "",
        "related": "COR",
        "source": "Alliance News",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=c4df09d07ee2a8d7a6394a9e289949da52dbbd2dbb9b1a592c5a68cda56beb9e"
    },
    {
        "category": "company",
        "datetime": 1725520980,
        "headline": "Cencora Announces EPS Forecast and Evernorth Contract Renewal",
        "id": 129729972,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=3d470f67085f6fa9eea5b057d2e62a5f211da49e4e20cb30aa0fe5cbfb871b1d"
    },
    {
        "category": "company",
        "datetime": 1725520500,
        "headline": "Cencora lifts FY24 earning guidance",
        "id": 129727569,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=f509fed297967c1ce6bea0f65108b98220b6a5d8ff2f13ee10fa5e3e3ae5faf4"
    },
    {
        "category": "company",
        "datetime": 1725483540,
        "headline": "Cencora Raises FY24 Outlook, Warns of Covid-19 Hit in FY25 Growth Views",
        "id": 131080828,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Cencora Raises FY24 Outlook, Warns of Covid-19 Hit in FY25 Growth Views",
        "url": "https://finnhub.io/api/news?id=e8b9e50fdb432a7517a118f750b95185b04407deb485f622990085fa469a01c1"
    },
    {
        "category": "company",
        "datetime": 1725093060,
        "headline": "Medical distributors, health plans ink $300M opioid settlement",
        "id": 129657366,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=9853ed3e18b107a274da51a54cede22e886d6d0a1f2cfc888c609e673d3c925f"
    },
    {
        "category": "company",
        "datetime": 1725019224,
        "headline": "Investing in Cencora (NYSE:COR) five years ago would have delivered you a 195% gain",
        "id": 129636210,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...",
        "url": "https://finnhub.io/api/news?id=5d3f310bfa318662f972154c0b9a6ee09bbeec13d857e60e1061f9f3aa617a1d"
    },
    {
        "category": "company",
        "datetime": 1724814360,
        "headline": "$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today",
        "id": 129609784,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=d725bd8d1530f96572ebf665c37c4b3d0080da49209fd1a0069998f2e62caa66"
    },
    {
        "category": "company",
        "datetime": 1724666580,
        "headline": "TD Cowen sees 'minimal' impact to Cencora FY25 EPS from Cigna change",
        "id": 129560861,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=c7d0cd3c9d1b21aa636253685b05ced82414872eaba60b16f3be742648863b6c"
    },
    {
        "category": "company",
        "datetime": 1724586540,
        "headline": "Stocks most loved and shunned by hedge and mutual funds",
        "id": 129552015,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=cea38b239cc67139e1b111f0e4320d064cc06bb2ab681cb99bfc1d6eb66f54be"
    },
    {
        "category": "company",
        "datetime": 1724437949,
        "headline": "ULVM: Unattractive Cocktail Of Value And Momentum",
        "id": 129531884,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1388634442/image_1388634442.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "The VictoryShares US Value Momentum ETF selects stocks using value and momentum scores and weighs them favoring low volatility. Learn more about ULVM stock here.",
        "url": "https://finnhub.io/api/news?id=253784b3dc18de3849c802af8e2fed493e0a208b51160b6925a04665acdf3f0c"
    },
    {
        "category": "company",
        "datetime": 1724238180,
        "headline": "Goldman Sachs\u2019 favorite mutual funds positions that are overweight the Russell 1000",
        "id": 129482521,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=b4d5fc5aeeaea93c1e0267b1c0a23b977232778ea8bbd80f0556bf4b8619cff4"
    },
    {
        "category": "company",
        "datetime": 1724216520,
        "headline": "Insider Selling: Cencora Inc (COR) CEO Steven Collis Sells 10,754 Shares",
        "id": 129512152,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=7df5e885e8c88700a9225bc156e1099952fd90eaa807d4eb94c50621ce81038b"
    },
    {
        "category": "company",
        "datetime": 1724060880,
        "headline": "Cencora's cure-all: A dose of data and distribution",
        "id": 129442311,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "Cencora is a key global player in pharmaceutical sourcing and distribution, enhancing patient access to essential products. The company serves a wide range of healthcare providers, offering...",
        "url": "https://finnhub.io/api/news?id=a91c58a61ca0d812c3b465c642ac9a6fae23c01cc43741247b65c00bc6ac577b"
    },
    {
        "category": "company",
        "datetime": 1723879119,
        "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 18",
        "id": 129421549,
        "image": "",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "",
        "url": "https://finnhub.io/api/news?id=4ca996f4af10ad94d8e1fe76647c4b306af9281cfc97657298930559040b3b32"
    },
    {
        "category": "company",
        "datetime": 1723779000,
        "headline": "Cencora Enhances Governance and Executive Compensation Structures",
        "id": 129409925,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=0360aab0d45860fcddce3bc11cf72bac1c6a316f15955d79adf3f95c9f170c1c"
    },
    {
        "category": "company",
        "datetime": 1723721400,
        "headline": "Cencora Elects Frank Clyburn to Its Board of Directors",
        "id": 129379147,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., August 15, 2024--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Frank Clyburn as a new independent director, effective October 1, 2024. With the election of Mr. Clyburn, the Board of Directors will increase to thirteen members.",
        "url": "https://finnhub.io/api/news?id=db3b14128770daaa95c2441e1b89ae7697663c44d89458d3da29e5f71c705b90"
    },
    {
        "category": "company",
        "datetime": 1723630680,
        "headline": "What's Driving Cardinal Health Inc's Surprising 11% Stock Rally?",
        "id": 129354744,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=aa0698effaffb7ee842bea62c14951f71e6d57aa14b8f0a212201d2ef37c9b21"
    },
    {
        "category": "company",
        "datetime": 1723627920,
        "headline": "Peering Into Cencora's Recent Short Interest",
        "id": 129362832,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=b74db57759f851f3dca8f5d7f5a995475e6b187521fcfd73ef0cf3423ed8e22c"
    },
    {
        "category": "company",
        "datetime": 1723616940,
        "headline": "Health Care Up After Cardinal Earnings -- Health Care Roundup",
        "id": 131080829,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Health Care Up After Cardinal Earnings -- Health Care Roundup",
        "url": "https://finnhub.io/api/news?id=9edc298c24706b621344c411aa253900053136e0667a86d895a01437e53e0a12"
    },
    {
        "category": "company",
        "datetime": 1723604100,
        "headline": "Invesco Health Care Fund Q2 2024 Review",
        "id": 129348664,
        "image": "",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "",
        "url": "https://finnhub.io/api/news?id=09e29f277a8100851c592eb9f299d9afa040ec711c7c415429faf63f3bcee5b5"
    },
    {
        "category": "company",
        "datetime": 1723374020,
        "headline": "Insiders At Cencora Sold US$13m In Stock, Alluding To Potential Weakness",
        "id": 129321608,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "The fact that multiple Cencora, Inc. ( NYSE:COR ) insiders offloaded a considerable amount of shares over the past year...",
        "url": "https://finnhub.io/api/news?id=f7398ebfea6af56e64ceb463ddd5dc02fd301786884637280d8bb5ae02575ec4"
    },
    {
        "category": "company",
        "datetime": 1723200360,
        "headline": "S&P 500 stocks that return more capital than their cost of capital - BofA",
        "id": 129261034,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=0bae885abb8297410bd2bb48fc83491149912e48634ae67c309ead572128d646"
    },
    {
        "category": "company",
        "datetime": 1723101540,
        "headline": "Argus Research Keeps Their Buy Rating on Cencora (COR)",
        "id": 129249500,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=d704ce717f707ee6acb7511cbe30177ffb0ba104535ef044cb3ec6e67963473e"
    },
    {
        "category": "company",
        "datetime": 1723094639,
        "headline": "Health Care Giant McKesson Dives Amid Big Revenue Miss",
        "id": 131043070,
        "image": "",
        "related": "COR",
        "source": "DowJones",
        "summary": "Health Care Giant McKesson Dives Amid Big Revenue Miss",
        "url": "https://finnhub.io/api/news?id=96f2e2cb7580109d904afdc2b8fdb85cf009a613097a5b3572810c2671836bef"
    },
    {
        "category": "company",
        "datetime": 1723023420,
        "headline": "Insider Sale: Executive Vice President Silvana Battaglia Sells Shares of Cencora Inc (COR)",
        "id": 129226619,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=8ad7480b43535b7acdd9a5fa1b38ae1fd6dd1e4b15516d16116e1ad5dbd95d2b"
    },
    {
        "category": "company",
        "datetime": 1723022220,
        "headline": "Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo",
        "id": 129226620,
        "image": "",
        "related": "COR",
        "source": "Dividend Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=475d717eae8b5a676e169aa67af24b5cfeedf2cc25e9b5df87b21abbe3d9b009"
    },
    {
        "category": "company",
        "datetime": 1722821520,
        "headline": "Analysts Are Bullish on Top Healthcare Stocks: Cencora (COR), Acadia Healthcare (ACHC)",
        "id": 129156921,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=23c5b80ca90da833c3a627d0d2342e9af3a7526a0f48b53cf2e35ebfc20752ea"
    },
    {
        "category": "company",
        "datetime": 1722775540,
        "headline": "Cencora (NYSE:COR) Could Be A Buy For Its Upcoming Dividend",
        "id": 129145063,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora, Inc. ( NYSE:COR ) stock is about to trade ex-dividend in four days. The ex-dividend date is one business day...",
        "url": "https://finnhub.io/api/news?id=3ada872e43f4af947b05ac21908306d173d881def9785188d7b818406a4fb879"
    },
    {
        "category": "company",
        "datetime": 1722665588,
        "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 4",
        "id": 129126421,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Read here for a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers.",
        "url": "https://finnhub.io/api/news?id=f9eb23400356a207608772d25a0b27fea6895c36c20e18fd8afea6d4cfd93a6c"
    },
    {
        "category": "company",
        "datetime": 1722614412,
        "headline": "All You Need to Know About Cencora (COR) Rating Upgrade to Buy",
        "id": 129106589,
        "image": "https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
        "url": "https://finnhub.io/api/news?id=b851a7ca5acbb433d0e53116159f3eb048c4b7713008c8362c9ec5ea624ec193"
    },
    {
        "category": "company",
        "datetime": 1722592380,
        "headline": "Cencora notified over 1.4M people about data being compromised, TechCrunch says",
        "id": 129113634,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=cc4eb72deba663352f4aa14d62505c5b2c1920f0ce300bfaaead018d3c5b7685"
    },
    {
        "category": "company",
        "datetime": 1722589560,
        "headline": "Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years",
        "id": 129113635,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=4220e15205030f63601696b702df07cd25af855d413c447a519c1ca34f8836d2"
    },
    {
        "category": "company",
        "datetime": 1722588720,
        "headline": "Walgreens plans to sell another slice of its Cencora stake for $1.1 billion",
        "id": 129112952,
        "image": "",
        "related": "COR",
        "source": "Associated Press, The",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=cd602d841cdb2c706702ffe72679e4bfa327aa990db9ad3ae555cddf5bb4ceee"
    },
    {
        "category": "company",
        "datetime": 1722586740,
        "headline": "Cencora 3.399M share Spot Secondary priced at $241.30",
        "id": 129113637,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=001d60f690fecb4f36a66740d2cc0bdde246f08d000c9a18974c519826ed4465"
    },
    {
        "category": "company",
        "datetime": 1722573660,
        "headline": "Walgreens further cuts stake in Cencora for $1.1B",
        "id": 129112955,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=9bbebd5c60c3ba6bfcdc44f2239653addf2b1393c83ec8c7de1a62536ef8e621"
    },
    {
        "category": "company",
        "datetime": 1722567540,
        "headline": "Walgreens continues to shed stake in Cencora as it looks to bolster turnaround",
        "id": 131080830,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Walgreens continues to shed stake in Cencora as it looks to bolster turnaround",
        "url": "https://finnhub.io/api/news?id=d50fb23259469fb9f3f7019fba838eb6bf2f1094408424766f6c283fd9c662ee"
    },
    {
        "category": "company",
        "datetime": 1722563220,
        "headline": "IN BRIEF: Walgreens Boots cuts stake in Cencora to 10% from 12%",
        "id": 129112958,
        "image": "",
        "related": "COR",
        "source": "Alliance News",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=756a3c2b56191673168c55c7cd1ca90f690c8eb1f7e27f465cbc4501895dc011"
    },
    {
        "category": "company",
        "datetime": 1722550620,
        "headline": "Cencora Announces Common Share Repurchase From Walgreens Boots Alliance",
        "id": 129094330,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., August 01, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $250 million in concurrence with Walgreens Boots Alliance\u2019s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.",
        "url": "https://finnhub.io/api/news?id=0e39cd4e6366dc92ba5ec29da9ca9ae15b130ab3f0ce47f7ba0cc6f7f1ee86dd"
    },
    {
        "category": "company",
        "datetime": 1722550080,
        "headline": "Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds",
        "id": 129091639,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "DEERFIELD, Ill., August 01, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold all of its remaining unencumbered shares of Cencora, Inc. (NYSE: COR) common stock pursuant to Rule 144 for proceeds of $818 million and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by Cencora in the amount of $250 million.",
        "url": "https://finnhub.io/api/news?id=663a0e84e2303149d2afec8b14ed6ffa00471a71d25a362be11bbd4e34bfc7d9"
    },
    {
        "category": "company",
        "datetime": 1722515816,
        "headline": "Cencora Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags",
        "id": 129064797,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora ( NYSE:COR ) Third Quarter 2024 Results Key Financial Results Revenue: US$74.2b (up 11% from 3Q 2023). Net...",
        "url": "https://finnhub.io/api/news?id=f0dc4145b92fb8b8060a3da8ebb76c67c7b9048eae6e29a7e198ec30a522e60f"
    },
    {
        "category": "company",
        "datetime": 1722510540,
        "headline": "Decoding Cencora Inc (COR): A Strategic SWOT Insight",
        "id": 129113640,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=b72cdf4c0043ce6bce972511658284521791df6ca820f90f420fa65eb85ac66d"
    },
    {
        "category": "company",
        "datetime": 1722500100,
        "headline": "Analysts Conflicted on These Healthcare Names: Cencora (COR), Schrodinger (SDGR) and Biogen (BIIB)",
        "id": 129068039,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=35112e5f83d10ecf749ccb8f74002a165967a60689b196c4cafbc1a96a757f06"
    },
    {
        "category": "company",
        "datetime": 1722499440,
        "headline": "Walgreens sells shares in Cencora for third time this year, raises $1.1 billion",
        "id": 131080831,
        "image": "",
        "related": "COR",
        "source": "MarketWatch",
        "summary": "Walgreens sells shares in Cencora for third time this year, raises $1.1 billion",
        "url": "https://finnhub.io/api/news?id=968ef3f5a2068be9a3fd0945742701fca69edd85f47d967770b55bdfdce1458e"
    },
    {
        "category": "company",
        "datetime": 1722498240,
        "headline": "Morgan Stanley Reaffirms Their Hold Rating on Cencora (COR)",
        "id": 129067571,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=3b7cc5a72089dd068c3864840c1bea04175af0d5a2f0fe48619e40847cd8e85a"
    },
    {
        "category": "company",
        "datetime": 1722490440,
        "headline": "Cencora price target raised by $2 at Baird, here's why",
        "id": 129083853,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=dc9a640073d5b143b536d234645e10621960fe4fd232611ac629616e9aea601c"
    },
    {
        "category": "company",
        "datetime": 1722490320,
        "headline": "Cencora price target raised by $13 at Wells Fargo, here's why",
        "id": 129083854,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=0d2ee2092f89115eb684cf9aca45ce144db17dc7ed1c7f3c4ac6bad108d78fa9"
    },
    {
        "category": "company",
        "datetime": 1722489000,
        "headline": "Walgreens sells shares of Cencora for roughly $1.1B of proceeds",
        "id": 129083855,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=c2e3e1a3d2e2dc3126643e638d37a182d92672bda5584822e43d42538f472bc6"
    },
    {
        "category": "company",
        "datetime": 1722487200,
        "headline": "Cencora\u2019s Hold Rating Maintained Amid Mixed Performance and Cautious Outlook",
        "id": 129067572,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=a89614743e300987436bbafff45e2b819f9855dd4f6587e97f97991f2bc8aa1b"
    },
    {
        "category": "company",
        "datetime": 1722481980,
        "headline": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Raffles Medical Group (OtherRAFLF), Cencora (COR) and Acadia Healthcare (ACHC)",
        "id": 129072745,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=afec66fea1bec38c18f26080169e0059de2ec5405ea0735bf6dfcb8e60d35cd2"
    },
    {
        "category": "company",
        "datetime": 1722480840,
        "headline": "Cencora (COR) Gets a Hold from Mizuho Securities",
        "id": 129067573,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=fc1e95ba52bb6df472744a55072867eec1cdfcf653dcc693ff33380ce2cd39e1"
    },
    {
        "category": "company",
        "datetime": 1722474300,
        "headline": "Cencora Inc (COR) Q3 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Raised ...",
        "id": 129083859,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=5871379aac6bd259813d30e6e8cee8779c17226267a65bbc207de4b212cdcaa1"
    },
    {
        "category": "company",
        "datetime": 1722424328,
        "headline": "Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript",
        "id": 129032322,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Cencora, Inc. (NYSE:NYSE:COR) Q3 2024 Earnings Conference Call July 31, 2024 8:30 AM ETCompany ParticipantsBennett Murphy - Senior Vice President, Head of...",
        "url": "https://finnhub.io/api/news?id=45d085eb45a7466ba739d4b3ccee946ea8c9cab74fc3c886e70c3bb20f72b4e1"
    },
    {
        "category": "company",
        "datetime": 1722422160,
        "headline": "Cencora\u2019s Resilient Growth and Strong Walgreens Alliance Affirm Buy Rating",
        "id": 129067574,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=83d221bb0004cf96ca834a8d8b56918fd28b2d3ec944fac888626229ac501d9e"
    },
    {
        "category": "company",
        "datetime": 1722421800,
        "headline": "Cencora Reports Fiscal 2024 Third Quarter Results",
        "id": 129032117,
        "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
        "related": "COR",
        "source": "Yahoo",
        "summary": "CONSHOHOCKEN, Pa., July 31, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent year-over-year to $74.2 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.42 for the third quarter of fiscal 2024 compared to $2.35 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below,",
        "url": "https://finnhub.io/api/news?id=57eb23f2f6baeba907f011ff6085ac0291d27493156ba0dec5c1fa1a5cc203c7"
    },
    {
        "category": "company",
        "datetime": 1722419700,
        "headline": "COR Stock Earnings: Cencora Beats EPS, Beats Revenue for Q3 2024",
        "id": 129048569,
        "image": "",
        "related": "COR",
        "source": "InvestorPlace",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=91b13a372dbebc29abc7738ae640cfc125648ee03d35aa3022b68561ad431838"
    },
    {
        "category": "company",
        "datetime": 1722417960,
        "headline": "Cencora revenue jumps 11% driven by demand for weight loss products",
        "id": 129048570,
        "image": "",
        "related": "COR",
        "source": "Alliance News",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=7e5a739661d1cb04e5d8f123a06613a0b59fa25e3e35241616205ca9acbd8a6c"
    },
    {
        "category": "company",
        "datetime": 1722415646,
        "headline": "Cencora, Inc. 2024 Q3 - Results - Earnings Call Presentation",
        "id": 129030840,
        "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "The following slide deck was published by Cencora, Inc.",
        "url": "https://finnhub.io/api/news?id=951bbd30323b207aa7e088cda834f2895781d392650d56df374e9aae4e354282"
    },
    {
        "category": "company",
        "datetime": 1722415080,
        "headline": "Evercore ISI Reaffirms Their Buy Rating on Cencora (COR)",
        "id": 129047815,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=0f1a3c8e41ab92aecb6efa6a25634b9cdfbbbe6b87a434bd654f4319f6ce93c9"
    },
    {
        "category": "company",
        "datetime": 1722409020,
        "headline": "Cencora declares $0.51 dividend",
        "id": 129048573,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=a20b350a1113f18568c0d463e4b6afd137d2072a278346bd93dea21e66251b45"
    },
    {
        "category": "company",
        "datetime": 1722408060,
        "headline": "Cencora: Fiscal Q3 Earnings Snapshot",
        "id": 129048574,
        "image": "",
        "related": "COR",
        "source": "Associated Press, The",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=efda1502ded492136f37984433dc08ecea5393f1cb8f8c007dad87e9aba4aa98"
    },
    {
        "category": "company",
        "datetime": 1722405120,
        "headline": "Cencora Inc (COR) Q3 2024 Earnings: Revenue Hits $74.2B, EPS at $2.42, Both Beating Estimates",
        "id": 129048576,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=6325d5fd273f6f1248fac355288712a2f48d4f3abf0ba98fb49381bf7333db09"
    },
    {
        "category": "company",
        "datetime": 1722404220,
        "headline": "Cencora beats Q2 estimates, updates FY guidance",
        "id": 129048579,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=5440953e3fbce9298161bb34e81c40c54ce5fb717baf09ececb7b47cad4c7d4a"
    },
    {
        "category": "company",
        "datetime": 1722404220,
        "headline": "Cencora raises FY24 adjusted EPS view to $13.55-$13.65 from $13.35-$13.55",
        "id": 129048578,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=925d79207be4036413d0a51ad0e262590edb5ba4c2cbe37be3b84eed6973d59c"
    },
    {
        "category": "company",
        "datetime": 1722404100,
        "headline": "Cencora reports Q3 adjusted EPS $3.34, consensus $3.22",
        "id": 129048580,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=47990444c246f63a0cca6c869e908360d16f18d3c41f0883fa28653de6ce4c56"
    },
    {
        "category": "company",
        "datetime": 1722397200,
        "headline": "Cencora Takes Over #195 Spot From Hess",
        "id": 129048581,
        "image": "",
        "related": "COR",
        "source": "The Online Investor",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=1bcd8f400e992b0f33b7cc354e8f038f0b88c420732d6645d296ff9e92a2221d"
    },
    {
        "category": "company",
        "datetime": 1722343140,
        "headline": "10 Health Care Stocks Whale Activity In Today's Session",
        "id": 129006928,
        "image": "",
        "related": "COR",
        "source": "Benzinga",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=effb2b90e7360c6f85a27a6945542c0b2835dc614524a9a824de52edd2a0c269"
    },
    {
        "category": "company",
        "datetime": 1722339660,
        "headline": "Cencora Q3 2024 Earnings Preview",
        "id": 129008912,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=3d2efd8b430496b128748d478837a2528759c3745ee867858d6546c69d4d105a"
    },
    {
        "category": "company",
        "datetime": 1722334740,
        "headline": "Notable earnings before Wednesday's open",
        "id": 129004363,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=a4ee3c6de691edb679f239004c3070d7e6c5ef584a9d4ff732d6178748ad599b"
    },
    {
        "category": "company",
        "datetime": 1721997493,
        "headline": "Cencora : Good Neighbor Pharmacy Network Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2024",
        "id": 128932430,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "Conshohocken, Pa. --Good Neighbor Pharmacy, a national independent pharmacy network offered through Cencora, convened more than 3,500 independent pharmacy owners and other partners to celebrate its...",
        "url": "https://finnhub.io/api/news?id=b19e957668921d9cf3ab7a5827259e6b481b8619bd575e452955c53f874df845"
    },
    {
        "category": "company",
        "datetime": 1721991618,
        "headline": "Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 81% Above Its Share Price",
        "id": 128929092,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Key Insights Using the 2 Stage Free Cash Flow to Equity, Cencora fair value estimate is US$411 Current share price of...",
        "url": "https://finnhub.io/api/news?id=e4c72d600bc070970328376a6f48558b30ee8e452dde79a2cb5046f405a71cc5"
    },
    {
        "category": "company",
        "datetime": 1721910600,
        "headline": "Do Options Traders Know Something About Cencora (COR) Stock We Don't?",
        "id": 128929093,
        "image": "https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Investors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately.",
        "url": "https://finnhub.io/api/news?id=dd94af6a29fc66c8879b18d1cd09e0c4ebe5d768ddd99a67e006df92257276ce"
    },
    {
        "category": "company",
        "datetime": 1721619420,
        "headline": "Barclays Sticks to Its Buy Rating for Cencora (COR)",
        "id": 128837493,
        "image": "",
        "related": "COR",
        "source": "TipRanks",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=48eceff6cd6216e42dfacf88a956f07d78a17cb53eabb5490b6af9e1b516e7bb"
    },
    {
        "category": "company",
        "datetime": 1721364780,
        "headline": "Citi opens 'positive catalyst watch' on Cencora into earnings",
        "id": 128805139,
        "image": "",
        "related": "COR",
        "source": "Thefly.com",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=a53db687e97b150a894097f1f3449923a30e266044f794bc040a5a9c6528e9c8"
    },
    {
        "category": "company",
        "datetime": 1721295300,
        "headline": "September 20th Options Now Available For Cencora (COR)",
        "id": 128761005,
        "image": "",
        "related": "COR",
        "source": "Stock Options Channel",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=37aa22f4e0ccf3592047de81b3affc3688e41e746089bf934c3dd8db0d7cba7c"
    },
    {
        "category": "company",
        "datetime": 1721210760,
        "headline": "Insider Sale: Steven Collis Sells 10,755 Shares of Cencora Inc (COR)",
        "id": 128761006,
        "image": "",
        "related": "COR",
        "source": "GuruFocus",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=70623996c7f8ca45ad5b69f9cf2d66f58c146c63263858b6113dc0beda1971ef"
    },
    {
        "category": "company",
        "datetime": 1721192220,
        "headline": "McKesson, Cardinal, Cencora interested in buying private cancer clinics - report",
        "id": 128738982,
        "image": "",
        "related": "COR",
        "source": "Seeking Alpha",
        "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.",
        "url": "https://finnhub.io/api/news?id=d5343cb2e7d2455fb6dd6367c92b154d0a6cf248f5386a41426cc919dc4f6518"
    },
    {
        "category": "company",
        "datetime": 1721107800,
        "headline": "TimesSquare Capital U.S. FOCUS Growth Equity Q2 2024 Commentary",
        "id": 128708962,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1903942443/image_1903942443.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "The portfolio outperformed the Russell Midcap Growth Index in the second quarter. Read more here.",
        "url": "https://finnhub.io/api/news?id=2a09cf2fe9ab1ada6a5213695ddb4089082cbe1f5d0a9b31650473872c639f31"
    },
    {
        "category": "company",
        "datetime": 1720714215,
        "headline": "Why Cencora (COR) is Poised to Beat Earnings Estimates Again",
        "id": 128659543,
        "image": "https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b",
        "related": "COR",
        "source": "Yahoo",
        "summary": "Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
        "url": "https://finnhub.io/api/news?id=a07b99afefb4435fcbfb3b0c0fe906a099785824a3615574b21002516eaa0ba5"
    },
    {
        "category": "company",
        "datetime": 1720694782,
        "headline": "Investing in Cencora (NYSE:COR) five years ago would have delivered you a 179% gain",
        "id": 128659544,
        "image": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
        "related": "COR",
        "source": "Yahoo",
        "summary": "When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...",
        "url": "https://finnhub.io/api/news?id=1d20c61fc0e48fb96669e0c8502f6866bc2c005fce298c18ff6d9b70ccffd32a"
    },
    {
        "category": "company",
        "datetime": 1720515637,
        "headline": "The Highest Quality Dividend Growth Stocks In 2024",
        "id": 128635284,
        "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305984152/image_1305984152.jpg?io=getty-c-w1536",
        "related": "COR",
        "source": "SeekingAlpha",
        "summary": "Dividend growth stocks passed stringent quality screens using a unique scoring system with 25 stocks meeting the criteria. Click here for the complete list.",
        "url": "https://finnhub.io/api/news?id=976e490a1851a3c716df9f11087a5c1aaeb5e78228dc1e71b89d099b212a4129"
    },
    {
        "category": "company",
        "datetime": 1720442100,
        "headline": "Outlook Therapeutics\u00ae Announces UK MHRA Marketing Authorization of LYTENAVA\u2122 (bevacizumab gamma) for the Treatment of Wet AMD",
        "id": 128627935,
        "image": "https://media.zenfs.com/en/globenewswire.com/a405eb2df242cead0aaeb90e54a8f460",
        "related": "COR",
        "source": "Yahoo",
        "summary": "UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA\u2122 (bevacizumab gamma) in the EU for the treatment of wet AMDInitial commercial launches of LYTENAVA\u2122 (bevacizumab gamma) in the EU and UK anticipated in calendar Q1 2025Strategic partnership with Cencora (formerly AmerisourceBergen) to support the planned commercial launches of LYTENAVA in UK and EU ISELIN, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a bio",
        "url": "https://finnhub.io/api/news?id=993b0637fc56bce09bb5828eb5c0aa332fb4e6b8d213d81ef0642db3c9af6f1c"
    },
    {
        "category": "company",
        "datetime": 1720433175,
        "headline": "Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release",
        "id": 128622042,
        "image": "",
        "related": "COR",
        "source": "Finnhub",
        "summary": "CONSHOHOCKEN - Cencora, Inc. today announced that it plans to release its results for the Third Quarter of Fiscal 2024 on Wednesday, July 31, 2024, prior to the opening of trading on the New York...",
        "url": "https://finnhub.io/api/news?id=8181fb8dc3a007027e686bea00d92fc73c59663820892e3583ab29dd77f5bf0f"
    }
]